L & S Advisors Inc Amarin Corp Plcuk Transaction History

L & S Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $1.11 Million - $1.85 Million	-79,907 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$16.27 - $20.51 $20,125 - $25,370	1,237 Added 1.57%	79,907 $1.55 Million
Q1 2019 May 14, 2019	BUY	$12.61 - $22.33 $992,028 - $1.76 Million	78,670 New	78,670 $1.63 Million
Q4 2018 Feb 14, 2019	SELL	$12.41 - $22.98 $2.8 Million - $5.19 Million	-225,799 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $553,207 - $3.67 Million	225,799 New	225,799 $3.67 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $181M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.